Recombinant antigens
p138
for Epstein-barr virus (EBV)
D-EA p138 is consideres as diffused (EA-D) early antigen. Regarding the EA-D, it is located in nucleus and cytoplasm and it has been described the highly presence of the diffuse early antigen of EBV in lymphomas and lymphoproliferative disorders. The D-EA p138 is an antigen codified by the gene BALF2 which is the major DNA binding protein of EBV. At the time of infection with Epstein-Barr virus, antibodies to EA are found and usually last for four to six months only. The absence of antibody to EA when other EBV antibodies are present strongly suggests that first time infection with EBV occurred in the past.
- NAME
- P138
- DESCRIPTION
- Early antigen
- GEN
- BALF2
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
References of Recombinant antigen p138
Folletos
- Rekom Biotech catalogue
- Recombinant proteins for in vitro diagnosis of human infectious diseases
- Sexually transmitted diseases (STD)
- Recombinant antigens for diagnosis of EBV
Videos
- How to reconsitute lyophizated vials
- Recombinant antigens for the diagnosis of Epstein-Barr Virus (EBV)
Related proteins
Reagent sheet
- NAME
- p138
- DESCRIPTION
- Early antigen
- PURITY
- >95% by observation on SDS-PAGE electrophoresis
- Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format
* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.
